Business Wire

THALES

16.3.2020 07:02:07 CET | Business Wire | Press release

Share
Thales, Telstra, Microsoft and Arduino Deliver Scalable Trust for Easy-to-deploy IoT Applications

Thales and Telstra, Australia’s leading telecommunications company are working with Microsoft and Arduino to pave the way for scalable security for connected IoT devices, by implementing a solution that enables trusted and secure end-to-end communication between device and cloud.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200315005014/en/

The solution enables instant and standardised mutual authentication between a device and a cloud platform via cellular networks, while fully-complying with GSMA IoT SAFE security specifications.

Within the IoT ecosystem, billions of devices collect, process and send data to the cloud, where a range of different IoT services are executed. To enable security, the IoT cloud service must have absolute trust in data received from connected devices. Equally, devices need to trust the cloud. This is only possible if the device and server are mutually authenticated. However, the IoT devices market is so fragmented - with a patchwork of different operating systems and chips being utilised - that security services scalability and duplication are very limited.

That’s why Thales, Telstra, Microsoft1 and Arduino2 decided to team up to work on a solution that addresses the challenge of securely and efficiently connecting IoT devices to clouds in the most simplified way and through cellular networks. The level of trust required is enabled by a sophisticated ‘security-by-design ’ approach for any IoT devices based on field-proven and standardised SIM or eSIM technology.

As a result, as soon as an IoT device is switched on, any SIM or eSIM featuring Thales’s IoT SAFE application is automatically and securely provisioned. Once the IoT device gets a proper Digital Certificate created and stored in the SIM/eSIM, then a trusted communication between the device and the server is permitted, in full respect of data integrity and confidentiality.

“The key role of GSMA IoT Safe specifications is to deliver scalable and future-proof IoT security for cellular networks. Being able to in future offer standardised easy to implement IoT security to our customers as part of our existing IoT connectivity service, is a huge leap forward in terms of IoT security for all use cases, including smart energy, automotive, health, and home solutions. We look forward to trialling this reference design with our IoT solutions,” said Gerhard Loots, Global IoT Solutions Executive at Telstra .

"As an active contributor of the GSMA specifications, and world leader in over-the-air platform solutions for credential life-cycle management, Thales is a key partner to address the challenge of scalable IoT security. With this hassle-free approach we support a sustainable and scalable trusted ecosystem from which all key stakeholders such as mobile network operators, device manufacturers, and IoT industries can benefit,” said Emmanuel Unguran, SVP Mobile and Connectivity Solutions at Thales .

“The collaborative effort between these international organizations demonstrates the importance of simplifying IoT security without compromise. By bringing together each IoT technology layer; device, software, network and cloud, we can deliver a more streamlined approach to IoT security. This allows customers and partners to focus on creating business value from their solutions while ensuring their IoT deployments remain secure,” said Tony Shakib, General Manager, Azure IoT Business Acceleration at Microsoft Corp.

"We are very pleased to be part of the dream team composed by Thales, Telstra and Microsoft" said Fabio Violante, CEO of Arduino. "The development of this tool was a teamwork and a proof that Arduino is a great partner to create solid, reliable and easy to integrate hardware and software IoT solutions."

About Thales

Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 80,000 employees in 68 countries, Thales generated sales of €19 billion in 2019 (on a pro forma basis including Gemalto over 12 months).

Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments.

PLEASE VISIT

Thales Group
Digital Security
Download HD photos

1 Microsoft integrated the IoT SAFE solution with their Azure IoT Hub and also provided Azure Stream Analytics, Cosmos DB and Power BI services to quickly enable the development of an example end-to-end IoT application.

2 Arduino developed a library (under an open-source licence) which implements the security mechanism of the GSMA IoT Safe standard on their MKR NB 1500 boards and provides a valid alternative to the usage of the CryptoChip already present on the Arduino board. The project has been a great example of collaboration with companies operating in various IoT sectors, on which Arduino focuses for professional and industrial applications through the brand new Arduino Pro division.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye